A Rapid Cytologic Double Staining of Epstein-Barr Virus-encoded Small RNA and Cell Surface Markers for Diagnosis of Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis

被引:1
作者
Takahashi, Natsuki [1 ]
Kudo, Ko [1 ]
Tanaka, Miyuki [3 ]
Kumagai, Naoya [2 ]
Sato, Tomohiko [1 ]
Kamio, Takuya [1 ]
Sasaki, Shinya [1 ]
Terui, Kiminori [1 ]
Kurose, Akira [2 ]
Yanagisawa, Ryu [3 ,4 ]
Nakazawa, Yozo [3 ]
Ito, Etsuro [1 ]
机构
[1] Hirosaki Univ, Grad Sch Med, Dept Pediat, 5 Zaifucho, Hirosaki, Aomori 0368562, Japan
[2] Hirosaki Univ, Grad Sch Med, Dept Anat Pathol, Hirosaki, Aomori, Japan
[3] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, Japan
[4] Shinshu Univ Hosp, Div Blood Transfus, Matsumoto, Nagano, Japan
基金
日本学术振兴会;
关键词
hemophagocytic lymphohistiocytosis; Epstein-Barr virus; Epstein-Barr virus– encoded small RNA; cytologic diagnosis; ETOPOSIDE;
D O I
10.1097/MPH.0000000000001647
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 3-year-old boy was clinically diagnosed with Epstein-Barr virus (EBV)-associated hemophagocytic lymphohistiocytosis. We identified EBV-infected CD8-positive T-lymphocytes by cytologic double staining of the peripheral blood for EBV-encoded small RNA and cell surface markers. The patient was subsequently administered immunosuppressive therapy with a reduced dose of etoposide because of previous organ damage. EBV clearance was confirmed by serial quantification of cell-fractionated EBV-DNA, whereas EBV-DNA persisted in the plasma for 18 weeks. Immunochemotherapy with low-dose etoposide combined with serial viral load monitoring is a potential therapeutic option for severe EBV-hemophagocytic lymphohistiocytosis cases with organ damage.
引用
收藏
页码:E756 / E758
页数:3
相关论文
共 14 条
[11]   Significance of Molecular Monitoring of T Cells for the Decision of Treatment Strategy for Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis [J].
Saito, Takamasa ;
Tanaka, Miyuki ;
Matsuda, Kazuyuki ;
Honma, Hitoshi ;
Komori, Kazutoshi ;
Morita, Daisuke ;
Nakazawa, Hideyuki ;
Yanagisawa, Ryu ;
Nakazawa, Yozo .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (05) :407-409
[12]   Cytologic Analysis of Epstein-Barr Virus-Associated T/Natural Killer-Cell Lymphoproliferative Diseases [J].
Yachie, Akihiro .
FRONTIERS IN PEDIATRICS, 2018, 6
[13]   Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol [J].
Yanagaisawa, Ryu ;
Matsuda, Kazuyuki ;
Ohga, Shouichi ;
Kanegane, Hirokazu ;
Morimoto, Akira ;
Okamoto, Yasuhiro ;
Ohara, Akira ;
Fukushima, Keitaro ;
Sotomatsu, Manabu ;
Nomura, Keiko ;
Saito, Akiko M. ;
Horibe, Keizo ;
Ishii, Eiichi ;
Nakazawa, Yozo .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (05) :612-617
[14]   Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan [J].
Yanagisawa, Ryu ;
Nakazawa, Yozo ;
Matsuda, Kazuyuki ;
Yasumi, Takahiro ;
Kanegane, Hirokazu ;
Ohga, Shouichi ;
Morimoto, Akira ;
Hashii, Yoshiko ;
Imaizumi, Masue ;
Okamoto, Yasuhiro ;
Saito, Akiko M. ;
Horibe, Keizo ;
Ishii, Eiichi .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (02) :206-213